AI promised faster drug discovery, lower costs, and reduced risk — but the reality has proven more nuanced. From an 80–90% Phase 1 success rate to high-profile pipeline cuts, this piece looks at where AI has genuinely delivered, where the hype has outpaced the science, and what it will take to build a credible, transparent path forward.

Devices that read our mind were once confined to the pages of futuristic novels, but they are gradually finding their way into reality. More

Our telehealth infrastructure is continuing to advance, with AI poised to transform appointment duration, quality of care, and physician ret

Evidencing its great promise in healthcare, AI is currently being used to advance our diagnostic capabilities for several diseases.